Apollo Medical Holdings, Inc. (AMEH) witnessed a remarkable surge of 7.6% during the last trading session, closing at $41.70, thanks to heightened trading volume. This spike contrasts with the stock’s 5.6% increase over the past four weeks.
A New Dawn: Astrana Health, Inc.
The positive momentum is fueled by Apollo Medical Holdings, Inc.’s transformation into Astrana Health, Inc. The decision to rebrand signifies a national expansion drive and a firm dedication to delivering top-notch healthcare services across local communities countrywide. With the upcoming change in corporate nomenclature, the company will transition to trading under the new symbol “ASTH” starting February 26, 2024.
Potential for Growth
Market analysts foresee Astrana Health, Inc. posting quarterly earnings of $0.17 per share, showcasing a remarkable year-over-year uptick of +750%. Revenue projections stand at $346.37 million, marking a 17.7% rise from the corresponding quarter in the previous year.
Steady Ascent
While earnings and revenue projections provide crucial insights into a stock’s potential, research indicates a strong correlation between shifts in earnings estimates and immediate stock price movements. In the case of Astrana Health, Inc., the consensus EPS estimate for the quarter has held steady over the past 30 days. Sustained upward momentum in stock prices typically follows a distinct trend in earnings estimate revisions. Investors keen on AMEH should keep a watchful eye on future developments to capitalize on this recent upsurge.
Industry Insights
As an integral part of the Zacks Medical Services sector, Apollo Medical Holdings, Inc. is closely watched by investors. Elevance Health (ELV), another player in the same industry, experienced a 0.6% increase in its latest trading session, closing at $512.17. Over the past month, ELV has delivered a solid return of 7.5%.
Elevance Health, in particular, has seen a 1.8% rise in the consensus EPS estimate for the upcoming report, now standing at $10.60. This marks a 12.1% improvement from the preceding year’s figures. Elevance Health currently holds a Zacks Rank of #2 (Buy).
Embracing Change
With the winds of change blowing in the medical industry, Astrana Health, Inc. stands as a symbol of growth and innovation. The forthcoming quarters are poised to unfold new chapters in the company’s narrative, hinting at more milestones in its journey towards success.
Just Released: Zacks Top 10 Stocks for 2024
Hurry – grab the chance to explore our top 10 picks for 2024. Curated by Zacks Director of Research, Sheraz Mian, this portfolio has consistently outperformed expectations. Since its inception in 2012 till November 2023, the Zacks Top 10 Stocks witnessed a staggering gain of +974.1%, nearly tripling the S&P 500’s +340.1% growth. Engage with Sheraz’s expert curation as he selects the top 10 stocks for you to consider this year. Be among the first to discover these high-potential stocks.
Want timely recommendations from Zacks Investment Research? Download the free report on the 7 best stocks for the upcoming 30 days by clicking here.
Apollo Medical Holdings, Inc. (AMEH) : Free Stock Analysis Report
Elevance Health, Inc. (ELV) : Free Stock Analysis Report
For the original article, visit Zacks.com by clicking here.
The opinions expressed are solely those of the author and do not necessarily reflect the views of Nasdaq, Inc.
